Tag: FDA
-
Congress upholds federal barriers to psychedelic drug research amidst broadening scientific acceptance
On Tuesday, members of the US House of representatives voted 140-285 against an amendment to a minibus appropriations bill that would have removed […]
-
Potential Alzheimer’s treatment approved by FDA
Biogen’s aducanamab could hit the market in a matter of days. While many in the Alzheimer’s community are encouraged by this news, the controversy surrounding the drug hasn’t gone anywhere.
-
What’s next for embattled Alzheimer’s drug aducanamab?
At a J.P. Morgan Healthcare panel on January 11, representatives for Biogen cited Eli Lilly’s positive Phase 2 study of Alzheimer’s drug donanemab […]
